Preview: Inovio Pharmaceuticals's Earnings
Portfolio Pulse from Benzinga Insights
Inovio Pharmaceuticals (NASDAQ:INO) is scheduled to release its quarterly earnings report on March 6, 2024, with an expected EPS of $-1.27. Analysts and investors will be closely watching for not only an earnings beat but also positive guidance for future growth. The company's past earnings performance shows a mix of hits and misses against estimates, with corresponding stock price fluctuations. Currently, INO shares are trading at $9.82, reflecting a 33.35% decline over the last year, indicating a bearish sentiment among long-term shareholders.
March 05, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Inovio Pharmaceuticals is expected to report an EPS of $-1.27 for the upcoming quarter. Past performance shows mixed results with stock price reactions. Shares are currently down 33.35% over the past year.
Given the expected EPS and the historical performance of INO around earnings announcements, the short-term impact on INO's stock price could be neutral. The anticipation of the earnings report may already be priced in, and without a significant beat or miss, the immediate reaction could be muted. However, guidance provided for future quarters will be crucial and could sway the stock price more significantly.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100